Block Admission Return

7 October 2011

Phorm, Inc.

('Phorm' or the 'Company')

Block Admission Return

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, is

providing an update to its block admission return filed on 8 April 2011 (the "Scheme").

For the period from 9 April 2011 to 8 October 2011, Phorm did not issue any securities under the Scheme and has the following balance of unissued securities under the Scheme:

As of 8 October 2011, the Company had an issued share capital of 18,479,907 common shares with a par value of $0.001 each, of which 17,582,569 are trading on AIM under the ticker PHRM, the restricted line and 897,338 are trading on AIM under the ticker PHRX, the unrestricted line. A further 45,000 common shares are held in treasury.

About Phorm:

Phorm is a global personalisation technology company that makes content and

advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience. Phorm's partners include leading ISPs, Publishers, Ad Networks and Advertisers.

Phorm is a Delaware, US incorporated company, with offices in Bucharest, London Sao Paulo and Seoul. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 150 employees and direct contractors. For more information, please visit: www.phorm.com

Enquiries:

Phorm, Inc.

Andy Croxson (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

Mirabaud Securities LLP +44 20 7321 2508

(Broker)

Jason Woollard

Peter Krens

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Advisor)

Mark Williams

Andrew Chubb